MARKET

IONS

IONS

Ionis Pharmaceuticals
NASDAQ
58.09
-0.04
-0.07%
After Hours: 52.29 -5.8 -9.98% 19:59 09/04 EDT
OPEN
58.36
PREV CLOSE
58.13
HIGH
58.96
LOW
57.78
VOLUME
2.67M
TURNOVER
--
52 WEEK HIGH
86.74
52 WEEK LOW
49.13
MARKET CAP
9.65B
P/E (TTM)
-16.7315
1D
5D
1M
3M
1Y
5Y
1D
Novartis Late-Stage Cardiovascular Outcome Study Fails, Stock Down
NASDAQ · 15h ago
Amgen Shares Fall as Novartis' Pelacarsen Misses Phase III Study Goal
NASDAQ · 15h ago
Citi sees limited immediate downside for Ionis after pelacarsen failure
TipRanks · 15h ago
Ionis Buy Rating Reiterated as Analyst Sees Limited Impact from Lp(a)HORIZON Setback and Maintains $100 Price Target
TipRanks · 16h ago
Weekly Report: what happened at IONS last week (0831-0904)?
Weekly Report · 21h ago
Does Pelacarsen’s Phase 3 Miss And ZANVASTRO’s FDA Win Change The Bull Case For Ionis (IONS)?
Simply Wall St · 2d ago
Stocks to Watch: Ionis Pharmaceuticals, Novartis, Corvex
Dow Jones · 3d ago
Ionis Pharmaceuticals Updates on Novartis Pelacarsen Trial Outcome
TipRanks · 3d ago
More
About IONS
Ionis Pharmaceuticals, Inc. develops six marketed medicines for serious diseases, including medicines for neurologic and cardiovascular diseases. Its marketed medicines consist of TRYNGOLZA, WAINUA (eplontersen), SPINRAZA (nusinersen), QALSODY (tofersen), TEGSEDI (inotersen) and WAYLIVRA (volanesorsen). TRYNGOLZA reduces triglyceride levels in adults with familial chylomicronemia syndrome (FCS). WAINUA is approved for the treatment of the polyneuropathy of hereditary transthyretin-medicated amyloidosis (ATTRv-PN) in adults. SPINRAZA is used for the treatment of pediatric and adult patients with spinal muscular atrophy. QALSODY is approved for the treatment of Amyotrophic Lateral Sclerosis in adults who have a mutation in the superoxide dismutase 1 (SOD1) gene, or SOD1-ALS. TEGSEDI is approved for the treatment of ATTRv-PN in adults. WAYLIVRA is approved as an adjunct to diet in adult patients with genetically confirmed FCS and at high risk of acute, potentially fatal pancreatitis.

Webull offers Ionis Pharmaceuticals Inc stock information, including NASDAQ: IONS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, IONS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading IONS stock methods without spending real money on the virtual paper trading platform.